New method separates cancer cells from normal cellsJune 16, 2009The vast majority of cancer deaths are due to metastasis, the spread of cancer cells from its primary site to other parts of the body. These metastatic cells tend to move more than their non-metastatic variants but this movement is poorly understood. Scientists are studying cancer cells intently with the hope they can learn to control the movements of the dangerous cells. Northwestern University researchers now have demonstrated a novel and simple method that can direct and separate cancer cells from normal cells. Based on this method, they have proposed that cancer cells possibly could be sequestered permanently in a sort of "cancer trap" made of implantable and biodegradable materials. The demonstrated device, which takes advantage of a physical principle called ratcheting, is a very tiny system of channels for cell locomotion. Each channel is less than a tenth of a millimeter wide. The asymmetric obstacles inside these channels direct cell movement along a preferred direction. Details are published online by the journal Nature Physics. "We have demonstrated a principle that offers an unconventional way to fight metastasis, a very different approach from other methods, such as chemotherapy," said Bartosz Grzybowski, the paper's senior author. "These are fundamental studies so the method needs to be optimized, but the idea has promise for a new approach to cancer therapy." Grzybowski is associate professor of chemical and biological engineering in the McCormick School of Engineering and Applied Science and associate professor of chemistry in the Weinberg College of Arts and Sciences. The researchers first discovered they could design channels of different geometries -- some a series of connected triangles -- through which cells can move in a single direction. (Live mammalian melanoma, breast cancer and normal cells were studied.) To create the channels, the researchers patterned cell-adhesive and cell-repellant chemical compounds onto a substrate. The cells stayed out of the repellant areas and localized onto the "ratchet" channels, which then directed the cells' movements. Grzybowski and his colleagues took this knowledge one critical step farther: they designed channels that successfully moved the cells of two types -- notably, cancerous and non-cancerous -- in opposite directions and thus partly sorted them out. To sort the cells, they took advantage of the cells' different shapes and mobility characteristics. Migrating cancer cells tend to be more round and broad while normal, epithelial cells are long and thin with long protrusions on the ends. The researchers designed a channel with "spikes" coming out at 45-degree angles from the walls, alternating on opposite sides of the channel. This pattern funnels cancer cells in one direction while at the same time directing the normal cells in the opposite direction, as those cells "grab" the spikes and pull themselves through. The researchers showed that a device with a number of these channels leading to a central reservoir, like spokes on a wheel, worked just as well separating cancer and non-cancerous cells. A stack of these radially arranged ratchet channels could be used to create a "cancer trap." "When implanted next to a tumor the particles would guide cancer cells, but not normal cells, inward to the reservoir, where they would be trapped," said Grzybowski. "The particles could also be part of the sutures used during surgical procedures." Northwestern University |
|||||||||||||||||||||
| Related Cancer Cells Current Events and Cancer Cells News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. New cancer target for non-Hodgkin's lymphoma Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. Common pain relief medication may encourage cancer growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Cancers' Sweet Tooth May Be Weakness The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Paradoxical protein might prevent cancer One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. Cornell researchers identify a weak link in cancer cell armor The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Researchers 'notch' a victory toward new kind of cancer drug Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. More Cancer Cells Current Events and Cancer Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||